Английская Википедия:HLA-DR5
HLA-DR5 (DR5) is a broad-antigen serotype that is further split into HLA-DR11 and HLA-DR12 antigen serotypes.
Serology
DRB1* | DR11 | DR5 | DR12 | Sample |
allele | % | % | % | size (N) |
11:01 | 92 | 5 | 3474 | |
11:02 | 89 | 3 | 430 | |
11:03 | 89 | 4 | 397 | |
11:04 | 87 | 4 | 2119 | |
11:05 | 75 | 4 | ||
11:06 | 20 | 73 | 15 | |
11:07 | >50 | 1 | ||
11:08 | >50 | 2 | ||
11:09 | 80 | 20 | 5 | |
. | ||||
DR12 | DR5 | DR11 | Sample | |
12:01 | 83 | 4 | 2 | 893 [2] |
12:02 | 89 | 162 | ||
12:03 | >50 | 3 | ||
12:06 | >50 | 2 |
Except for a few DRB1* alleles, the reactivity of DR5 is relatively poor.
Disease associations
DR5 is associated with persistent generalized lymphadenopathy[3] and Kaposi's sarcoma in AIDS,[4] juvenile rheumatoid arthritis,[5][6] pernicious anemia, Hashimoto's thyroiditis,[7][8] mycosis fungoides,[9] polyglandular deficiency syndrome,[10] systemic sclerosis,[11][12] childhood epilepsy,[13] early-onset alopecia areata,[14] short-ragweed Ra6 allergy,[15] primary antiphospholipid syndrome,[16] and increased longevity in the Dutch.[17]
Genetic linkage
HLA-DR5 reactive gene products are linked to serology of HLA-DRB3 (HLA-DR52).
References
Шаблон:Reflist Шаблон:DR serotypes
- ↑ derived from IMGT/HLA
- ↑ DR8 - 2%
- ↑ Шаблон:Cite journal
- ↑ Шаблон:Cite journal
- ↑ Шаблон:Cite journal
- ↑ Шаблон:Cite journal
- ↑ Шаблон:Cite journal
- ↑ Шаблон:Cite journal
- ↑ Шаблон:Cite journal
- ↑ Шаблон:Cite journal
- ↑ Шаблон:Cite journal
- ↑ Шаблон:Cite journal
- ↑ Шаблон:Cite journal
- ↑ Шаблон:Cite journal
- ↑ Шаблон:Cite journal
- ↑ Шаблон:Cite journal
- ↑ Шаблон:Cite journal